Kelley Weinfurtner, MD
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
421 Curie Blvd, 910 BRB II/III
Philadelphia, PA 19104
Philadelphia, PA 19104
Education
BA (Bachelor of Arts, Molecular and Cell Biology)
University of California Berkeley, 2007.
MD (Doctor of Medicine)
University of California San Francisco, 2015.
MSTR (Translational Research)
University of Pennsylvania, 2024.
Permanent linkBA (Bachelor of Arts, Molecular and Cell Biology)
University of California Berkeley, 2007.
MD (Doctor of Medicine)
University of California San Francisco, 2015.
MSTR (Translational Research)
University of Pennsylvania, 2024.
Description of Clinical Expertise
I am a transplant hepatologist who cares for patients with a wide range of liver problems. In particular, I have significant expertise in caring for patients with advanced liver disease and patients with liver tumors.Description of Research Expertise
My research is centered around developing precision medicine strategies for patients with primary liver cancers. In particular, I have expertise in developing patient-derived models of primary liver cancer for use in translational therapeutics.Selected Publications
Bukola Adebesin, Kelley Weinfurtner, Alexander Zavriyev, Molly Sheehan, Stephen Kadlecek, David Tischfield, Terence P. Gade: Multimodal 18F-FDG PET and Hyperpolarized [1-13C] Pyruvate Magnetic Resonance Spectroscopy for Subtype-Specific Treatment Response Prediction in Hepatocellular Carcinoma World Molecular Imaging Congress Annual Meeting September 2026 Notes: Abstract ID: 450.Isabella Farkas, Kelley Weinfurtner, Kim Olthoff, Peter Abt, Fady Kaldas, Mark Rosen, Gentian Lluri, Jack Rychik, Maarouf Hoteit, Yuli Kim: Incidental Hepatocellular Carcinoma on Explant Pathology in Patients With Fontan Circulation After Combined Heart-Liver Transplantation. JACC Case Reports August 2026.
Boehmler D, Baron R, Crainic J, Islam A, Kim Y, Gurevich A, Perkons N, Zavriyev A, Amin R, Andrew-Udoh J, Tuzneen Supan E, El Ghazal R, Hunt SJ, McClung G, Tischfield D, Ackerman D, Weljie A, Weinfurtner K, Skuli N, Gade TPF.: Locoregional Lactate Dehydrogenase Inhibition Potentiates Therapy and Overcomes Treatment Resistance in Hepatocellular Carcinoma. Hepatology April 2026 Notes: doi: 10.1097/HEP.0000000000001775. Online ahead of print.
Weinfurtner K, Amin R, Skuli N, Gade TPF, Kaplan DE: Patient-derived models of liver cancer to inform therapeutic decision: recent updates. Seminars in Liver Disease 46: 51-62, March 2026.
Yan L, Huang L, Wright C, Gade TPF, Weinfurtner K: Intra-patient tumor-level outcomes of transarterial chemoembolization versus transarterial radioembolization for multifocal hepatocellular carcinoma. Society of Interventional Oncology Annual Meeting February 2026.
Bukola Y. Adebesin: Multiparametric Hyperpolarized-13C-MRI for Sensitive Assessment of Early-Stage Liver Disease. AASLD Annual Liver Meeting 2026.
Kim Y, McClung G, Wright C, Tischfield D, Furth EE, Kaffe E, Weinfurtner K, Gade TPF: Hepatocyte Humanization in an SRG Rat Model After Partial Hepatectomy. AASLD The Liver Meeting November 2025.
Hoteit MA, Abt PL, Priore SF, Tondon R, Abu-Gazala A, Agarwal P, Weinfurtner K, Hilscher MB, Wangensteeen KJ: Molecular patterns associated with recurrence and survival in intrahepatic cholangiocarcinoma (iCCA) / hepatocholangiocarcinoma (HCC-CCA) after liver transplantation. AASLD The Liver Meeting November 2025.
Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei, TH, Singal A, Hoteit MA, Park LS, Kaplan DE, Lo Re V.: Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes. Pharmacoepidemiol Drug Saf 34(5): e70154, May 2025.
Hoteit M, Weinfurtner K: Recurrent hepatocellular carcinoma after liver transplantation: Small steps, while awaiting a breakthrough. Liver Transplantation April 2025 Notes: Online ahead of print. doi: 10.1097/LVT.0000000000000571.